{"entity":{"type":"insider","cik":"0001284851","url":"/insider/0001284851","json_url":"/insider/0001284851.json","name":"LEVERNIER MICHAEL J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":48,"n_filings":38,"first":"2004-10-26","last":"2005-07-12","span_basis":"filed_date"},"name_variants":[{"name":"LEVERNIER MICHAEL J","source":"filing","n_filings":38,"first_seen":"2004-10-26","last_seen":"2005-07-12"}],"transactions":[{"id":1410762,"accession":"0001181431-05-039923","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-039923","line_url":"/filing/0001181431-05-039923","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":16.575757575757574,"price_display":"16.58","price_state":"stated","total_value":54700.0,"total_display":"54,700.00","total_whole":"54,700","shares_owned_after":189252.0,"shares_owned_after_display":"189,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-11","filed_date":"2005-07-12","scope":"insider","n_lines":2},{"id":1261193,"accession":"0001181431-05-039288","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-039288","line_url":"/filing/0001181431-05-039288","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":16.875757575757575,"price_display":"16.88","price_state":"stated","total_value":55690.0,"total_display":"55,690.00","total_whole":"55,690","shares_owned_after":192552.0,"shares_owned_after_display":"192,552","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-05","filed_date":"2005-07-07","scope":"insider","n_lines":2},{"id":1328503,"accession":"0001181431-05-036954","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-036954","line_url":"/filing/0001181431-05-036954#line-2","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":17.55,"price_display":"17.55","price_state":"stated","total_value":35100.0,"total_display":"35,100.00","total_whole":"35,100","shares_owned_after":195852.0,"shares_owned_after_display":"195,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-27","filed_date":"2005-06-27","scope":"insider"},{"id":1328502,"accession":"0001181431-05-036954","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-036954","line_url":"/filing/0001181431-05-036954#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":17.85,"price_display":"17.85","price_state":"stated","total_value":23205.0,"total_display":"23,205.00","total_whole":"23,205","shares_owned_after":197852.0,"shares_owned_after_display":"197,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-24","filed_date":"2005-06-27","scope":"insider"},{"id":1475735,"accession":"0001181431-05-036153","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-036153","line_url":"/filing/0001181431-05-036153","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":16.233333333333334,"price_display":"16.23","price_state":"stated","total_value":53570.0,"total_display":"53,570.00","total_whole":"53,570","shares_owned_after":200452.0,"shares_owned_after_display":"200,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-20","filed_date":"2005-06-22","scope":"insider","n_lines":2},{"id":1269153,"accession":"0001181431-05-034896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-034896","line_url":"/filing/0001181431-05-034896","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":15.33909090909091,"price_display":"15.34","price_state":"stated","total_value":50619.0,"total_display":"50,619.00","total_whole":"50,619","shares_owned_after":203752.0,"shares_owned_after_display":"203,752","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-13","filed_date":"2005-06-15","scope":"insider","n_lines":2},{"id":1377599,"accession":"0001181431-05-033323","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-033323","line_url":"/filing/0001181431-05-033323","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":15.321515151515152,"price_display":"15.32","price_state":"stated","total_value":50561.0,"total_display":"50,561.00","total_whole":"50,561","shares_owned_after":207052.0,"shares_owned_after_display":"207,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-06","filed_date":"2005-06-06","scope":"insider","n_lines":2},{"id":1214364,"accession":"0001181431-05-031801","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-031801","line_url":"/filing/0001181431-05-031801","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":15.385757575757577,"price_display":"15.39","price_state":"stated","total_value":50773.0,"total_display":"50,773.00","total_whole":"50,773","shares_owned_after":210352.0,"shares_owned_after_display":"210,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-31","filed_date":"2005-05-31","scope":"insider","n_lines":2},{"id":1198123,"accession":"0001181431-05-030306","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-030306","line_url":"/filing/0001181431-05-030306","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":15.2033,"price_display":"15.20","price_state":"stated","total_value":50170.89,"total_display":"50,170.89","total_whole":"50,171","shares_owned_after":213652.0,"shares_owned_after_display":"213,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-23","filed_date":"2005-05-24","scope":"insider","n_lines":2},{"id":1523659,"accession":"0001181431-05-028569","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-028569","line_url":"/filing/0001181431-05-028569","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":15.545757575757575,"price_display":"15.55","price_state":"stated","total_value":51301.0,"total_display":"51,301.00","total_whole":"51,301","shares_owned_after":216952.0,"shares_owned_after_display":"216,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-16","filed_date":"2005-05-17","scope":"insider","n_lines":2},{"id":1619418,"accession":"0001181431-05-026738","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-026738","line_url":"/filing/0001181431-05-026738","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":16.5191,"price_display":"16.52","price_state":"stated","total_value":54513.03,"total_display":"54,513.03","total_whole":"54,513","shares_owned_after":220252.0,"shares_owned_after_display":"220,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-09","filed_date":"2005-05-09","scope":"insider","n_lines":2},{"id":1580362,"accession":"0001181431-05-024873","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-024873","line_url":"/filing/0001181431-05-024873#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":16.85,"price_display":"16.85","price_state":"stated","total_value":33700.0,"total_display":"33,700.00","total_whole":"33,700","shares_owned_after":222252.0,"shares_owned_after_display":"222,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-02","filed_date":"2005-05-02","scope":"insider"},{"id":1478717,"accession":"0001181431-05-023414","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-023414","line_url":"/filing/0001181431-05-023414#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":17.77,"price_display":"17.77","price_state":"stated","total_value":35540.0,"total_display":"35,540.00","total_whole":"35,540","shares_owned_after":224252.0,"shares_owned_after_display":"224,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-04-25","filed_date":"2005-04-25","scope":"insider"},{"id":1570747,"accession":"0001181431-05-022427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-022427","line_url":"/filing/0001181431-05-022427#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":17.25,"price_display":"17.25","price_state":"stated","total_value":34500.0,"total_display":"34,500.00","total_whole":"34,500","shares_owned_after":226252.0,"shares_owned_after_display":"226,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-04-18","filed_date":"2005-04-18","scope":"insider"},{"id":1584957,"accession":"0001181431-05-021760","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-021760","line_url":"/filing/0001181431-05-021760#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":19.6,"price_display":"19.60","price_state":"stated","total_value":39200.0,"total_display":"39,200.00","total_whole":"39,200","shares_owned_after":228252.0,"shares_owned_after_display":"228,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-04-11","filed_date":"2005-04-12","scope":"insider"},{"id":1655870,"accession":"0001181431-05-020633","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-020633","line_url":"/filing/0001181431-05-020633#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":18.65,"price_display":"18.65","price_state":"stated","total_value":37300.0,"total_display":"37,300.00","total_whole":"37,300","shares_owned_after":230252.0,"shares_owned_after_display":"230,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-04-04","filed_date":"2005-04-05","scope":"insider"},{"id":1560607,"accession":"0001181431-05-018837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-018837","line_url":"/filing/0001181431-05-018837#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":18.99,"price_display":"18.99","price_state":"stated","total_value":37980.0,"total_display":"37,980.00","total_whole":"37,980","shares_owned_after":232252.0,"shares_owned_after_display":"232,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-28","filed_date":"2005-03-28","scope":"insider"},{"id":1228458,"accession":"0001181431-05-018152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-018152","line_url":"/filing/0001181431-05-018152#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":17.415,"price_display":"17.42","price_state":"stated","total_value":34830.0,"total_display":"34,830.00","total_whole":"34,830","shares_owned_after":234252.0,"shares_owned_after_display":"234,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-21","filed_date":"2005-03-22","scope":"insider"},{"id":1294197,"accession":"0001181431-05-016815","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-016815","line_url":"/filing/0001181431-05-016815#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":18.676,"price_display":"18.68","price_state":"stated","total_value":37352.0,"total_display":"37,352.00","total_whole":"37,352","shares_owned_after":236252.0,"shares_owned_after_display":"236,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-14","filed_date":"2005-03-15","scope":"insider"},{"id":1592825,"accession":"0001181431-05-015384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-015384","line_url":"/filing/0001181431-05-015384#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":17.87,"price_display":"17.87","price_state":"stated","total_value":35740.0,"total_display":"35,740.00","total_whole":"35,740","shares_owned_after":238252.0,"shares_owned_after_display":"238,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-07","filed_date":"2005-03-08","scope":"insider"},{"id":1578755,"accession":"0001181431-05-013141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-013141","line_url":"/filing/0001181431-05-013141#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":16.071,"price_display":"16.07","price_state":"stated","total_value":32142.0,"total_display":"32,142.00","total_whole":"32,142","shares_owned_after":240252.0,"shares_owned_after_display":"240,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-28","filed_date":"2005-02-28","scope":"insider"},{"id":1498478,"accession":"0001181431-05-012135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-012135","line_url":"/filing/0001181431-05-012135#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":17.09,"price_display":"17.09","price_state":"stated","total_value":34180.0,"total_display":"34,180.00","total_whole":"34,180","shares_owned_after":242252.0,"shares_owned_after_display":"242,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-22","filed_date":"2005-02-23","scope":"insider"},{"id":1604222,"accession":"0001181431-05-010357","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-010357","line_url":"/filing/0001181431-05-010357#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":17.7,"price_display":"17.70","price_state":"stated","total_value":35400.0,"total_display":"35,400.00","total_whole":"35,400","shares_owned_after":244252.0,"shares_owned_after_display":"244,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-14","filed_date":"2005-02-16","scope":"insider"},{"id":1693753,"accession":"0001181431-05-007586","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-007586","line_url":"/filing/0001181431-05-007586#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":13.7998,"price_display":"13.80","price_state":"stated","total_value":27599.6,"total_display":"27,599.60","total_whole":"27,600","shares_owned_after":246252.0,"shares_owned_after_display":"246,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-07","filed_date":"2005-02-07","scope":"insider"},{"id":1331538,"accession":"0001181431-05-005777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-005777","line_url":"/filing/0001181431-05-005777#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":13.6192,"price_display":"13.62","price_state":"stated","total_value":27238.4,"total_display":"27,238.40","total_whole":"27,238","shares_owned_after":248252.0,"shares_owned_after_display":"248,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-01-31","filed_date":"2005-01-31","scope":"insider"},{"id":1465025,"accession":"0001181431-05-004548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-004548","line_url":"/filing/0001181431-05-004548#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.2683,"price_display":"12.27","price_state":"stated","total_value":24536.6,"total_display":"24,536.60","total_whole":"24,537","shares_owned_after":250252.0,"shares_owned_after_display":"250,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-01-24","filed_date":"2005-01-24","scope":"insider"},{"id":1693737,"accession":"0001181431-05-003249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-003249","line_url":"/filing/0001181431-05-003249#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.4828,"price_display":"12.48","price_state":"stated","total_value":24965.6,"total_display":"24,965.60","total_whole":"24,966","shares_owned_after":252252.0,"shares_owned_after_display":"252,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-01-18","filed_date":"2005-01-18","scope":"insider"},{"id":1684628,"accession":"0001181431-05-002558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-002558","line_url":"/filing/0001181431-05-002558#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.6472,"price_display":"12.65","price_state":"stated","total_value":25294.4,"total_display":"25,294.40","total_whole":"25,294","shares_owned_after":254252.0,"shares_owned_after_display":"254,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-01-10","filed_date":"2005-01-12","scope":"insider"},{"id":1423278,"accession":"0001181431-05-000804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-000804","line_url":"/filing/0001181431-05-000804#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.1,"price_display":"12.10","price_state":"stated","total_value":24200.0,"total_display":"24,200.00","total_whole":"24,200","shares_owned_after":256252.0,"shares_owned_after_display":"256,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-01-03","filed_date":"2005-01-04","scope":"insider"},{"id":417727,"accession":"0001181431-04-060921","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-04-060921","line_url":"/filing/0001181431-04-060921#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.15,"price_display":"12.15","price_state":"stated","total_value":24300.0,"total_display":"24,300.00","total_whole":"24,300","shares_owned_after":258252.0,"shares_owned_after_display":"258,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-12-27","filed_date":"2004-12-28","scope":"insider"},{"id":574543,"accession":"0001181431-04-059816","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-04-059816","line_url":"/filing/0001181431-04-059816#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.65,"price_display":"12.65","price_state":"stated","total_value":25300.0,"total_display":"25,300.00","total_whole":"25,300","shares_owned_after":260252.0,"shares_owned_after_display":"260,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-12-20","filed_date":"2004-12-20","scope":"insider"},{"id":277358,"accession":"0001181431-04-058362","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-04-058362","line_url":"/filing/0001181431-04-058362#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.1845,"price_display":"12.18","price_state":"stated","total_value":24369.0,"total_display":"24,369.00","total_whole":"24,369","shares_owned_after":262252.0,"shares_owned_after_display":"262,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-12-13","filed_date":"2004-12-13","scope":"insider"},{"id":574462,"accession":"0001181431-04-057160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-04-057160","line_url":"/filing/0001181431-04-057160#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.8,"price_display":"11.80","price_state":"stated","total_value":23600.0,"total_display":"23,600.00","total_whole":"23,600","shares_owned_after":264252.0,"shares_owned_after_display":"264,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-12-06","filed_date":"2004-12-07","scope":"insider"},{"id":661156,"accession":"0001181431-04-055527","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-04-055527","line_url":"/filing/0001181431-04-055527#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.36,"price_display":"11.36","price_state":"stated","total_value":22720.0,"total_display":"22,720.00","total_whole":"22,720","shares_owned_after":266252.0,"shares_owned_after_display":"266,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-11-29","filed_date":"2004-11-30","scope":"insider"},{"id":270683,"accession":"0001181431-04-054534","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-04-054534","line_url":"/filing/0001181431-04-054534#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.411,"price_display":"11.41","price_state":"stated","total_value":22822.0,"total_display":"22,822.00","total_whole":"22,822","shares_owned_after":268252.0,"shares_owned_after_display":"268,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-11-22","filed_date":"2004-11-22","scope":"insider"},{"id":574441,"accession":"0001181431-04-053099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-04-053099","line_url":"/filing/0001181431-04-053099#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.1,"price_display":"10.10","price_state":"stated","total_value":20200.0,"total_display":"20,200.00","total_whole":"20,200","shares_owned_after":270252.0,"shares_owned_after_display":"270,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-11-15","filed_date":"2004-11-16","scope":"insider"},{"id":517867,"accession":"0001181431-04-051541","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-04-051541","line_url":"/filing/0001181431-04-051541#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.2,"price_display":"11.20","price_state":"stated","total_value":22400.0,"total_display":"22,400.00","total_whole":"22,400","shares_owned_after":272252.0,"shares_owned_after_display":"272,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-11-08","filed_date":"2004-11-09","scope":"insider"},{"id":470031,"accession":"0001181431-04-050469","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-04-050469","line_url":"/filing/0001181431-04-050469#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.5,"price_display":"10.50","price_state":"stated","total_value":21000.0,"total_display":"21,000.00","total_whole":"21,000","shares_owned_after":274252.0,"shares_owned_after_display":"274,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-11-01","filed_date":"2004-11-03","scope":"insider"},{"id":504205,"accession":"0001181431-04-048911","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-04-048911","line_url":"/filing/0001181431-04-048911#line-1","is_derivative":false,"issuer_cik":"0001162461","issuer_name":"CUTERA INC","issuer_ticker":"CUTR","issuer_name_source":null,"issuer_url":"/issuer/0001162461","owner_cik":"0001284851","owner_name":"LEVERNIER MICHAEL J","owner_display_name":"LEVERNIER MICHAEL J","owner_url":"/insider/0001284851","role":"Officer (VP of Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP of Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":9.34,"price_display":"9.34","price_state":"stated","total_value":18680.0,"total_display":"18,680.00","total_whole":"18,680","shares_owned_after":276252.0,"shares_owned_after_display":"276,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-10-25","filed_date":"2004-10-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":48,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":48,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":48},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001162461","name":"CUTERA INC","url":"/issuer/0001162461","role":"Officer (VP of Clinical Development)","n_filings":38,"first_seen":"2004-10-26","last_seen":"2005-07-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001284851","retrieved_at":"2026-08-23T18:42:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}